Literature DB >> 28557554

Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases.

Michael A Avallone1, Bryan S Sack1, Ahmad El-Arabi1, David K Charles1, William R Herre1, Andrew C Radtke1, Carley M Davis1, William A See1.   

Abstract

OBJECTIVES: To evaluate the rate of perioperative complications after plasmakinetic bipolar and monopolar transurethral resection of bladder tumor (BTURB and MTURB). In addition, the study identifies patient and procedure characteristics associated with early complications. PATIENTS AND METHODS: Retrospective review was conducted on patients undergoing transurethral resection of bladder tumor procedures at a single institution from 2003 to 2013 to assess the 30-day complication rates associated with BTURB and MTURB.
RESULTS: Four hundred twenty-seven patients met inclusion criteria and underwent 586 procedures (379 BTURB and 207 MTURB). Baseline patient demographics, tumor stage, and tumor grade were similar in BTURB and MTURB cohorts. The overall complication rate was 34.3% for MTURB and 26.7% for BTURB. The most frequent complications were acute urinary retention (AUR) 11%, hematuria 8%, and urinary tract infection (UTI) 7%. There was no statistical difference in rates of AUR, hematuria, UTI, or readmission for continuous bladder irrigation or hemostasis procedures between BTURB and MTURB cohorts. There was a trend toward lower perforation rate during BTURB (2.6% vs 5.8%). In multivariate logistic regression analysis, MTURB, male gender, and large resections were predictive of overall complications. Male gender was associated with hematuria and AUR. Large bladder tumor resection size was also associated with increased risk of overall complications and AUR.
CONCLUSION: BTURB was associated with a lower risk of overall complications, but there was no difference in the rate of hematuria in the two cohorts. Male gender and large tumor size are associated with higher risk of early complications.

Entities:  

Keywords:  bladder cancer; plasmakinetic bipolar resection; transurethral resection of bladder tumors

Mesh:

Year:  2017        PMID: 28557554      PMCID: PMC5568593          DOI: 10.1089/end.2017.0056

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  22 in total

Review 1.  Bipolar transurethral resection of the prostate: the 'golden standard' reclaims its leading position.

Authors:  Charalampos Mamoulakis; Marleen Trompetter; Jean de la Rosette
Journal:  Curr Opin Urol       Date:  2009-01       Impact factor: 2.309

Review 2.  Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Charalampos Mamoulakis; Dirk T Ubbink; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2009-07-07       Impact factor: 20.096

3.  Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.

Authors:  Kathleen Herkommer; Christian Hofer; Juergen E Gschwend; Martina Kron; Uwe Treiber
Journal:  J Urol       Date:  2012-03-14       Impact factor: 7.450

4.  Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting.

Authors:  Alan M Nieder; David S Meinbach; Sandy S Kim; Mark S Soloway
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

Review 5.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

Review 6.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Authors:  Marko Babjuk; Maximilian Burger; Richard Zigeuner; Shahrokh F Shariat; Bas W G van Rhijn; Eva Compérat; Richard J Sylvester; Eero Kaasinen; Andreas Böhle; Joan Palou Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

7.  Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate.

Authors:  Charalampos Mamoulakis; Andreas Skolarikos; Michael Schulze; Cesare M Scoffone; Jens J Rassweiler; Gerasimos Alivizatos; Roberto M Scarpa; Jean J M C H de la Rosette
Journal:  BJU Int       Date:  2011-05-09       Impact factor: 5.588

8.  Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial.

Authors:  Alessandro Del Rosso; Gianna Pace; Stefano Masciovecchio; Pietro Saldutto; Giuseppe Paradiso Galatioto; Carlo Vicentini
Journal:  Int J Urol       Date:  2012-09-25       Impact factor: 3.369

Review 9.  Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis.

Authors:  Chenming Zhao; Kun Tang; Huan Yang; Ding Xia; Zhiqiang Chen
Journal:  J Endourol       Date:  2015-10-08       Impact factor: 2.942

10.  Use of bipolar energy for transurethral resection of superficial bladder tumors: long-term results.

Authors:  Xiao-Yong Pu; Huai-Peng Wang; Yi-Long Wu; Xing-Huan Wang
Journal:  J Endourol       Date:  2008-03       Impact factor: 2.942

View more
  3 in total

1.  The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

Authors:  Stefania Zamboni; Marco Moschini; Andrea Gallina; Renzo Colombo; Francesco Montorsi; Alberto Briganti; Andrea Salonia; Alessandro Antonelli; Claudio Simeone; Sandra Belotti; Luca Cristinelli; Agostino Mattei; Philipp Baumeister
Journal:  World J Urol       Date:  2019-03-25       Impact factor: 4.226

2.  Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.

Authors:  K Kent Chevli; Neal D Shore; Andrew Trainer; Angela B Smith; Daniel Saltzstein; Yaron Ehrlich; Jay D Raman; Boris Friedman; Richard D'Anna; David Morris; Brian Hu; Mark Tyson; Alexander Sankin; Max Kates; Jennifer Linehan; Douglas Scherr; Steven Kester; Michael Verni; Karim Chamie; Lawrence Karsh; Arnold Cinman; Andrew Meads; Soumi Lahiri; Madlen Malinowski; Nimrod Gabai; Sunil Raju; Mark Schoenberg; Elyse Seltzer; William C Huang
Journal:  J Urol       Date:  2021-08-26       Impact factor: 7.450

3.  Transurethral en bloc resection with monopolar current for non-muscle invasive bladder cancer based on TNM system.

Authors:  Yongjun Yang; Chao Liu; Xiaofeng Yang; Dongwen Wang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.